Skip Navigation

Company News, 2013-07-10, 01:46 PM

ThyssenKrupp investing in industrial biotechnology

Europe’s first multi-purpose fermentation plant for the continuous production of bio-based chemicals is being inaugurated in Leuna, Saxony-Anhalt/Germany today. Built at a cost of around 20 million euros, the facility will enable ThyssenKrupp to further expand its research and development activities in the area of biochemicals based on renewable raw materials. Among other things, these biochemicals are used as starting materials for biodegradable plastics such as polylactic acid (PLA) and polybutylene succinate (PBS).

Bioplastics are ideal for processing into packaging materials, films and textiles. It is expected that some 4.5 million tons of polyethylene (PET) a year will be replaced by bioplastics in the coming years, helping reduce environmental impact and conserve resources.

ThyssenKrupp CEO Dr. Heinrich Hiesinger sees significant market potential: “Modern biotechnology is one of the key technologies of the 21st century. Biotechnological processes, products and services play a role in almost all areas of our daily lives – for example in the development of new medicines, plant varieties, detergents and cosmetics. Industrial biotechnology is part of our growth strategy. ThyssenKrupp has extensive expertise in this area – from basic research to the operation of industrial-scale pilot plants.”

Secretary of state Marco Tullner from Saxony-Anhalt’s Ministry of Science and Economic Affairs believes the investment will further strengthen Leuna’s position as a center for chemicals: “Saxony-Anhalt has evolved into an innovative business location. A qualified workforce, attractive commercial and industrial zones, and a well-developed infrastructure offer ideal conditions – including for industry. The opening of the ThyssenKrupp facility in Leuna shows that we have created clear advantages here for future technologies.”

An interdisciplinary team of engineers and scientists from ThyssenKrupp’s plant technology business worked for five years to develop a licensable process for the production of lactic acid. The company’s technical center for research into biochemicals was relocated from Leipzig to Leuna in August 2012. The multi-purpose fermentation plant inaugurated today will enable ThyssenKrupp to test its laboratory-developed fermentation and processing technologies on an industrial scale: More than 1,000 metric tons of biochemicals such as lactic acid and succinic acid can now be produced at this facility annually.

To the top